Moreover, metformin treatment of ovarian cancer cells significantly decreased both mRNA and protein levels of Axl and Tyro3 in a dose-dependent manner, indicating that metformin suppresses AXL and TYRO3 expression at the transcriptional level. This evidence concerns the gene AXL and ovarian cancer.